Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis: a Randomized Controlled Trial, Ibn-Sina Hospital, Baghdad 2022

NCT05193877 is registered in ClinicalTrials.gov with Global Stem Cell Center, Baghdad as lead sponsor.

NCT NCT05193877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05193877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis: a Randomized Controlled Trial, Ibn-Sina Hospital, Baghdad 2022
Lead sponsor
Global Stem Cell Center, Baghdad
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2022
Completion date
January 16, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment complication